Over the years, the VAP has received funding from various sources, both public and private. At first, funding for India was provided through PL-480 rupees from the U.S. India fund and by the Department of Biotechnology (DBT), Government of India. The U.S. Agency for International Development also supported the VAP from 1983–1987. Subsequently, the New York-based Starr Foundation donated two million dollars to the NIAID Restricted Gift Fund in order to expand, through VAP, the number of collaborative projects between Indian and American scientists. Currently, awards to the Indian institutions are made entirely through the DBT and/or ICMR
Research awards to promote specific U.S-India collaborations in the context of the VAP are made to U.S. institutions through the NIAID Division of Microbiology and Infectious Diseases (DMID) and other NIAID divisions.
Some extramural U.S. investigators may be funded through the National Institutes of Health (NIH) R03 mechanism. A DMID/NIAID R03 grant provides up to $50,000 direct costs per year for up to two years. The R03 awards are not renewable. Information about these R03 grants may be found under the VAP Program Announcement (PA-16-163).
Intramural NIH investigators and other federal scientists may be eligible for research support of comparable duration and scope through various interagency agreements.
In addition, information about an NIAID International Research in Infectious Diseases, including AIDS (IRIDA) R01 Program (PAR-14-080), which provides support to "institutions or organizations located in resource- constrained countries," is also available online. This mechanism may also provide Indian institutions working on VAP projects with additional funds to expand their research focus and collaborations.
For further information on the above grant mechanisms, please contact Dr. Polly Sager.
For other information on VAP, please contact Dr. Ranjan Gupta.
Last Updated April 26, 2016